GL1X · GenesisL1 explorer

UniProt Q05397

Focal adhesion kinase 1 (Q05397)

Focal adhesion kinase 1 (UniProt Q05397), EC 2.7.1.112, 2.7.10.2: 71 experimental structures and 1 predicted model on GenesisL1, 28 ligands bound, 262 pockets. Binding sites, druggability and experiment against prediction…

UniProt
Q05397
Protein
Focal adhesion kinase 1
EC
2.7.1.112, 2.7.10.2
Experimental structures
71
Predicted models
1
Ligands
28
Pockets
262 · 45 records with a druggable one

Structures

72 records of Q05397 in the MolNFT archive: 71 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1K04Crystal Structure of the Focal Adhesion Targeting Domain of Focal Adhesion Kinasex-ray diffractionACL1 (best 0.34)
1K04Crystal structure of the focal adhesion targeting domain of focal adhesion kinasex-ray diffractionACL1 (best 0.34)
1K05Crystal structure of the Focal Adhesion Targeting Domain of Focal Adhesion Kinasex-ray diffractionA, B, C—6 (best 0.49)
1K05Crystal structure of the focal adhesion targeting domain of focal adhesion kinasex-ray diffractionA, B, C—6 (best 0.49)
1MP8Crystal structure of Focal Adhesion Kinase (FAK)x-ray diffractionAADP1 (best 0.65)
1MP8Crystal structure of focal adhesion kinase (fak)x-ray diffractionAADP1 (best 0.65)
1OW6Paxillin LD4 motif bound to the Focal Adhesion Targeting (FAT) domain of the Focal Adhesion Kinasex-ray diffractionA, B, C—8 (best 0.41)
1OW6Paxillin LD4 motif bound to the focal adhesion targeting (fat) domain of the focal adhesion kinasex-ray diffractionA, B, C—8 (best 0.41)
1OW7Paxillin LD4 motif bound to the Focal Adhesion Targeting (FAT) domain of the Focal Adhesion Kinasex-ray diffractionA, B, C—8 (best 0.47)
1OW7Paxillin LD4 motif bound to the focal adhesion targeting (fat) domain of the focal adhesion kinasex-ray diffractionA, B, C—8 (best 0.47)
1OW8Paxillin LD2 motif bound to the Focal Adhesion Targeting (FAT) domain of the Focal Adhesion Kinasex-ray diffractionA, B, C—8 (best 0.44)
1OW8Paxillin LD2 motif bound to the focal adhesion targeting (fat) domain of the focal adhesion kinasex-ray diffractionA, B, C—8 (best 0.44)
2ETMCrystal Structure of Focal Adhesion Kinase Domain Complexed with 7H-Pyrrolo [2,3-d] pyrimidine…x-ray diffractionA, B7PY4 (best 0.69)
2ETMCrystal structure of focal adhesion kinase domain complexed with 7H-pyrrolo [2,3-D] pyrimidine…x-ray diffractionA, B7PY4 (best 0.69)
2IJMCrystal Structure of Focal Adhesion Kinase Domain with 2 molecules in the Asymmetric Unit Complexed…x-ray diffractionA, BATP, ADP2 (best 0.67)
2IJMCrystal structure of focal adhesion kinase domain with 2 molecules in the asymmetric unit complexed…x-ray diffractionA, BATP, ADP2 (best 0.67)
3B71CD4 endocytosis motif bound to the Focal Adhesion Targeting (FAT) domain of the Focal Adhesion…x-ray diffractionA, B, C—7 (best 0.42)
3B71CD4 endocytosis motif bound to the focal adhesion targeting (fat) domain of the focal adhesion…x-ray diffractionA, B, C—7 (best 0.42)
3BZ3Crystal Structure Analysis of Focal Adhesion Kinase with a Methanesulfonamide Diaminopyrimidine…x-ray diffractionAYAM2 (best 0.61)
3BZ3Crystal structure analysis of focal adhesion kinase with a methanesulfonamide diaminopyrimidine…x-ray diffractionAYAM2 (best 0.61)
3S9OThe Focal Adhesion Targeting (FAT) domain of the Focal Adhesion Kinase showing N-terminal…x-ray diffractionA, B, CNA, CL7 (best 0.48)
3S9OThe focal adhesion targeting (fat) domain of the focal adhesion kinase showing N-terminal…x-ray diffractionA, B, CNA, CL7 (best 0.48)
4EBVStructure of Focal Adhesion Kinase catalytic domain in complex with novel allosteric inhibitorx-ray diffractionA0O71 (best 0.78)
4EBVStructure of focal adhesion kinase catalytic domain in complex with novel allosteric inhibitorx-ray diffractionA0O71 (best 0.78)
4EBWStructure of Focal Adhesion Kinase catalytic domain in complex with novel allosteric inhibitorx-ray diffractionA0PF1 (best 0.78)
4EBWStructure of focal adhesion kinase catalytic domain in complex with novel allosteric inhibitorx-ray diffractionA0PF1 (best 0.78)
4GU6FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH…x-ray diffractionA, B10N5 (best 0.65)
4GU6Focal adhesion kinase catalytic domain in complex with N-{3-[(5-cyano…x-ray diffractionA, B10N5 (best 0.65)
4GU9Focal adhesion kinase catalytic domain in complex with…x-ray diffractionA, B4GU3 (best 0.72)
4GU9Focal adhesion kinase catalytic domain in complex with (2-fluoro…x-ray diffractionA, B4GU3 (best 0.72)
4I4EStructure of Focal Adhesion Kinase catalytic domain in complex with hinge binding…x-ray diffractionA1BQ1 (best 0.61)
4I4EStructure of focal adhesion kinase catalytic domain in complex with hinge binding…x-ray diffractionA1BQ1 (best 0.61)
4I4FStructure of Focal Adhesion Kinase catalytic domain in complex with an allosteric binding…x-ray diffractionA1BR1 (best 0.80)
4I4FStructure of focal adhesion kinase catalytic domain in complex with an allosteric binding…x-ray diffractionA1BR1 (best 0.80)
4K8AFragment-based discovery of Focal Adhesion Kinase Inhibitorsx-ray diffractionA, BK8A4 (best 0.68)
4K8AFragment-based discovery of focal adhesion kinase inhibitorsx-ray diffractionA, BK8A4 (best 0.68)
4K9YFOCAL ADHESION KINASE Catalytic domain in complex with…x-ray diffractionAK9Y1 (best 0.74)
4K9YFocal adhesion kinase catalytic domain in complex with 1-[4-(6-amino…x-ray diffractionAK9Y1 (best 0.74)
4KABFOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 3-Methyl-1,4-dihydro-pyrazolo[4,5-c]pyrazolex-ray diffractionA, B4KA4 (best 0.73)
4KABFocal adhesion kinase catalytic domain in complex with 3-methyl-1,4- dihydro-PYRAZOLO[4,5-C]PYRAZOLEx-ray diffractionA, B4KA4 (best 0.73)
4KAOFOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH…x-ray diffractionA, BKAO, SO44 (best 0.70)
4KAOFocal adhesion kinase catalytic domain in complex with 1-(5-tert…x-ray diffractionA, BKAO, SO44 (best 0.70)
4NY0Crystal structure of FERM domain of human focal adhesion kinasex-ray diffractionD, A, B, C—11 (best 0.71)
4NY0Crystal structure of ferm domain of human focal adhesion kinasex-ray diffractionD, A, B, C—11 (best 0.71)
4Q9SCrystal Structure of human Focal Adhesion Kinase (Fak) bound to Compound1…x-ray diffractionA30G1 (best 0.62)
4Q9SCrystal structure of human focal adhesion kinase (fak) bound to COMPOUND1…x-ray diffractionA30G1 (best 0.62)
6I8ZCrystal structure of PTK2 in complex with BI-4464.x-ray diffractionAH821 (best 0.64)
6I8ZCrystal structure of PTK2 in complex with bi-4464.x-ray diffractionAH821 (best 0.64)
6LES3D domain-swapped dimer of the maltose-binding protein fused to a fragment of the focal adhesion…x-ray diffractionA, B, X, YSO47 (best 0.78)
6LES3D domain-swapped dimer of the maltose-binding protein fused to a fragment of the focal adhesion…x-ray diffractionA, B, X, YSO47 (best 0.78)
6PW8Hydrocarbon-Stapled Paxillin Peptide Bound to the Focal Adhesion Targeting (FAT) Domain of the…x-ray diffractionAZN, CL—
6PW8Hydrocarbon-stapled paxillin peptide bound to the focal adhesion targeting (fat) domain of the…x-ray diffractionAZN, CL—
6YOJFOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH…x-ray diffractionAP4N1 (best 0.61)
6YOJFocal adhesion kinase catalytic domain in complex with 6-[4-(3…x-ray diffractionAP4N—
6YQ1FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH…x-ray diffractionA, B, C, DP7N, NA, SO413 (best 0.82)
6YQ1Focal adhesion kinase catalytic domain in complex with N-methyl-N-(3…x-ray diffractionA, B, C, DP7N, NA, SO4—
6YR9FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH…x-ray diffractionA, B, C, DP9K10 (best 0.65)
6YR9Focal adhesion kinase catalytic domain in complex with N-methyl-N-(2…x-ray diffractionA, B, C, DP9K—
6YT6FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH…x-ray diffractionA, BPKE, SO43 (best 0.66)
6YT6Focal adhesion kinase catalytic domain in complex with N-methyl-N-(3…x-ray diffractionA, BPKE, SO4—

12 records more on the page itself.

Ligands

  • SO4 · Sulfate ion · in 14 records
  • CL · Chloride ion · in 6 records
  • ADP · Adenosine-5'-diphosphate · in 4 records
  • NA · Sodium ion · in 4 records
  • ZN · Zinc ion · in 4 records
  • 0O7 · 8-(4-ethylphenyl)-5-methyl-2,5-dihydropyrazolo[4,3-c][2,1]benzothiazine 4,4-dioxide · in 2 records
  • 0PF · 1-ethyl-8-(4-ethylphenyl)-5-methyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazine 4,4-dioxide · in 2 records
  • 10N · N-(3-{[(5-cyano-2-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)amino]methyl}pyridin-2-yl)-N-methylmethanesulfonamide · in 2 records
  • 1BQ · [4-(2-hydroxyethyl)piperidin-1-yl][4-(5-methyl-4,4-dioxido-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazin-8-yl)phenyl]methanone · in 2 records
  • 1BR · N-(4-tert-butylbenzyl)-1,5-dimethyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazin-8-amine 4,4-dioxide · in 2 records
  • 30G · 3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1H)-one · in 2 records
  • 4GU · N-(2-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine · in 2 records
  • 4KA · 3-methyl-1,5-dihydropyrazolo[4,3-c]pyrazole · in 2 records
  • 7PY · 7-pyridin-2-yl-N-(3,4,5-trimethoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine · in 2 records
  • ATP · Adenosine-5'-triphosphate · in 2 records
  • H82 · 3-methoxy-~{N}-(1-methylpiperidin-1-ium-4-yl)-4-[[4-[(3-oxidanylidene-1,2-dihydroinden-4-yl)oxy]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide · in 2 records
  • K8A · 3-bromo-5-(2H-tetrazol-5-yl)pyridine · in 2 records
  • K9Y · 1-[4-(6-amino-9H-purin-9-yl)phenyl]-3-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]urea · in 2 records
  • KAO · 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[4-(pyridin-3-yl)phenyl]urea · in 2 records
  • P1E · 4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide · in 2 records
  • P4N · 6-[[4-[(3-methylsulfonylphenyl)methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-3,4-dihydro-1~{H}-quinolin-2-one · in 2 records
  • P7N · ~{N}-methyl-~{N}-[3-[[[2-[(2-oxidanylidene-3,4-dihydro-1~{H}-quinolin-6-yl)amino]-5-(trifluoromethyl) pyrimidin-4-yl]amino]methyl]pyridin-2-yl]methanesulfonamide · in 2 records
  • P9K · N-Methyl-N-(2-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-phenyl)-methanesulfonamide · in 2 records
  • PKE · ~{N}-methyl-~{N}-[3-[[[2-[(2-oxidanylidene-1,3-dihydroindol-5-yl)amino]pyrimidin-4-yl]amino]methyl]pyridin-2-yl]methanesulfonamide · in 2 records
  • PVT · 5-[[4-(pyridin-3-ylmethylamino)-5-(trifluoromethyl) pyrimidin-2-yl]amino]-1,3-dihydroindol-2-one · in 2 records
  • Q2H · ~{N}-methyl-~{N}-[3-[(~{E})-[2-phenylazanyl-5-(trifluoromethyl)pyrimidin-4-yl]iminomethyl]pyridin-2-yl]methanesulfonamide · in 2 records
  • YAM · N-methyl-N-{3-[({2-[(2-oxo-2,3-dihydro-1H-indol-5-yl) amino]-5-(trifluoromethyl)pyrimidin-4-yl}amino) methyl]pyridin-2-yl}methanesulfonamide · in 2 records
  • 7QB · (2S,4R)-4-hydroxy-1-((S)-2-(2-(4-(3-methoxy-4-((4-((2-(methylcarbamoyl)phenyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)phenyl)piperazin-1-yl)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.